Iwasaki M - Search Results

1

ERα increases endometrial cancer cell resistance to cisplatin via upregulation of BAG3.

Abe S, Iwasaki M, Habata S, Mariya T, Tamate M, Matsuura M, Satohisa S, Saito T. Abe S, et al. Among authors: iwasaki m. Oncol Lett. 2021 Jan;21(1):20. doi: 10.3892/ol.2020.12281. Epub 2020 Nov 9. Oncol Lett. 2021. PMID: 33240426 Free PMC article.

2

Prediction of histologic type and lymph node metastasis for advanced ovarian cancer on uterine cervical and endometrial cytology.

Suzuki M, Suzuki T, Matsuura M, Iwasaki M, Tanaka R, Ito E, Fujii M, Saito T. Suzuki M, et al. Among authors: iwasaki m. Acta Cytol. 2010 Jul-Aug;54(4):575-81. doi: 10.1159/000325180. Acta Cytol. 2010. PMID: 20715659

3

BAG3 (BCL2-associated athanogene 3) interacts with MMP-2 to positively regulate invasion by ovarian carcinoma cells.

Suzuki M, Iwasaki M, Sugio A, Hishiya A, Tanaka R, Endo T, Takayama S, Saito T. Suzuki M, et al. Among authors: iwasaki m. Cancer Lett. 2011 Apr 1;303(1):65-71. doi: 10.1016/j.canlet.2011.01.019. Epub 2011 Feb 12. Cancer Lett. 2011. PMID: 21316839

4

[Mechanism of metastasis in endometrial cancer].

Saito T, Tanaka R, Iwasaki M. Saito T, et al. Among authors: iwasaki m. Nihon Rinsho. 2012 Jun;70 Suppl 4:317-20. Nihon Rinsho. 2012. PMID: 23156263 Japanese. No abstract available.

5

Prediction of the therapeutic effect of dienogest in ovarian endometrial cysts using the apparent diffusion coefficient.

Matsuura M, Tamate M, Tabuchi Y, Takada S, Tanaka R, Iwasaki M, Saito T. Matsuura M, et al. Among authors: iwasaki m. Gynecol Endocrinol. 2014 Aug;30(8):597-9. doi: 10.3109/09513590.2014.911277. Epub 2014 May 8. Gynecol Endocrinol. 2014. PMID: 24811093 Free article.

6

BAG3 upregulates Mcl-1 through downregulation of miR-29b to induce anticancer drug resistance in ovarian cancer.

Sugio A, Iwasaki M, Habata S, Mariya T, Suzuki M, Osogami H, Tamate M, Tanaka R, Saito T. Sugio A, et al. Among authors: iwasaki m. Gynecol Oncol. 2014 Sep;134(3):615-23. doi: 10.1016/j.ygyno.2014.06.024. Epub 2014 Jun 30. Gynecol Oncol. 2014. PMID: 24992675

7

BAG3 increases the invasiveness of uterine corpus carcinoma cells by suppressing miR-29b and enhancing MMP2 expression.

Habata S, Iwasaki M, Sugio A, Suzuki M, Tamate M, Satohisa S, Tanaka R, Saito T. Habata S, et al. Among authors: iwasaki m. Oncol Rep. 2015 May;33(5):2613-21. doi: 10.3892/or.2015.3831. Epub 2015 Mar 4. Oncol Rep. 2015. PMID: 25738313

8

Palonosetron in combination with 1-day versus 3-day dexamethasone for prevention of nausea and vomiting following paclitaxel and carboplatin in patients with gynecologic cancers: A randomized, multicenter, phase-II trial.

Matsuura M, Satohisa S, Teramoto M, Tanaka R, Iwasaki M, Nishikawa A, Mizunuma M, Tanaka S, Hayakawa O, Saito T. Matsuura M, et al. Among authors: iwasaki m. J Obstet Gynaecol Res. 2015 Oct;41(10):1607-13. doi: 10.1111/jog.12748. Epub 2015 Jul 21. J Obstet Gynaecol Res. 2015. PMID: 26199182 Clinical Trial.

9

BAG3-mediated Mcl-1 stabilization contributes to drug resistance via interaction with USP9X in ovarian cancer.

Habata S, Iwasaki M, Sugio A, Suzuki M, Tamate M, Satohisa S, Tanaka R, Saito T. Habata S, et al. Among authors: iwasaki m. Int J Oncol. 2016 Jul;49(1):402-10. doi: 10.3892/ijo.2016.3494. Epub 2016 Apr 21. Int J Oncol. 2016. PMID: 27120977

10

Rap1GAP inhibits tumor progression in endometrial cancer.

Tamate M, Tanaka R, Osogami H, Matsuura M, Satohisa S, Iwasaki M, Saito T. Tamate M, et al. Among authors: iwasaki m. Biochem Biophys Res Commun. 2017 Apr 1;485(2):476-483. doi: 10.1016/j.bbrc.2017.02.044. Epub 2017 Feb 11. Biochem Biophys Res Commun. 2017. PMID: 28196746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,595 results

Search Page

Filters